Sulodexide Completed Phase 3 Trials for Diabetic Nephropathies Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00130208Effect of Sulodexide in Early Diabetic Nephropathy